FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and concerns a fused solid dispersion of ibuprofen and waterless light silicic acid of specific surface area 20 to 400 m2/g which can be suitable to be tabletted without any coating problems and adhesion, and also concerns a tablet containing the specified fused solid dispersion.
EFFECT: oral introduction of such tablet can maintain a constant release over extended intervals.
37 cl, 11 tbl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINING POLMACOXIB AND PREGABALIN FOR TREATMENT OF PAIN | 2019 |
|
RU2789402C1 |
| DRUG COMPOSITIONS CONTAINING CONTROLLED RELEASE HYPROMELLOSE MATRIXES | 2006 |
|
RU2414241C2 |
| NIMESULIDE-CONTAINING SUSTAINED-RELEASE COMPOSITIONS | 2000 |
|
RU2238087C2 |
| COMBINED PHARMACEUTICAL WITH TABLET IN CORE, CONTAINING MOSAPRIDE AND RABEPRAZOLE | 2018 |
|
RU2753697C1 |
| CONTROLLED-RELEASE HYDROCODON COMPOSITION | 2001 |
|
RU2253452C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING DIACEREIN | 2009 |
|
RU2542461C2 |
| PROLONGED RELEASE TABLET CONTAINING THEOBROMIN | 2010 |
|
RU2506947C2 |
| PREPARATIONS OF DELAYED RELEASE FOR PERORAL INTAKE | 2001 |
|
RU2277416C2 |
| PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION WITH MASKED TASTE AND PREPARATION METHOD THEREOF | 2012 |
|
RU2583935C2 |
| CONTROLLED-RELEASE FORMULATION | 2006 |
|
RU2385712C2 |
